期刊
NATURE REVIEWS NEUROLOGY
卷 16, 期 11, 页码 597-598出版社
NATURE RESEARCH
DOI: 10.1038/s41582-020-00414-3
关键词
-
Despite negative findings from numerous clinical trials of potential disease-modifying therapies for Alzheimer disease, amyloid remains the most compelling therapeutic target. Advances in biomarker methods now enable accurate monitoring of Alzheimer disease progression from the earliest stages of the disease. We must therefore redouble efforts to find an effective treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据